Mol Cell Endocrinol 418:4254 Lorenz M, Evers A, Wagner M (2013) Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity
Here, our data demonstrate that, similar to T3 (Figs
Research has discovered that metformin can achieve its glucose-lowering effect through the gut-liver axis and the gut-liver-brain axis
HOLST: I'm following this field very closely, because it's so important
As noted by Manasyan et al., while these agents reduce insulin requirements and maintain adequate glucose control with fewer hypoglycemic events, they may simultaneously impede adequate nutrition as a result of delayed gastric emptying and present a risk of aspiration
There are six in Connecticut, one in New Hampshire, and none in Rhode Island, which could lead some patients to travel for the drugs